West Lafayette, IN, United States of America

Lisa Lynn McQueen

This inventor holds 15 USPTO granted patents and 6 published patent applications and 2 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Dermira, Inc., Salix Pharmaceuticals, Inc., Journey Medical Corporation. Active years: 2012-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lisa Lynn McQueen. Retrieved from https://idiyas.com/inventor/lisa-lynn-mcqueen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 15 

% Patents Active = 100.0

 

Average Co-Inventor Count = 7.9

ph-index = 6

Forward Citations = 95(Granted Patents)


Company Filing History:


Years Active: 2012-2022

Loading Chart...
Loading Chart...
Areas of Expertise:
Glycopyrrolate Salts
Rifaximin Forms
Crystalline Glycopyrrolate Tosylate
Pharmaceutical Chemistry
Drug Formulations
Active Ingredients
Chemical Compounds
Salt Forms
Medicinal Chemistry
Therapeutic Uses
15 patents (USPTO):Explore Patents

Title: The Innovations of Lisa Lynn McQueen

Introduction

Lisa Lynn McQueen, an accomplished inventor based in West Lafayette, IN, has made significant contributions to the field of pharmaceuticals with a focus on innovative treatments. With an impressive portfolio of 15 patents, her work has advanced medical options available for patients suffering from various conditions, particularly hyperhidrosis.

Latest Patents

Among her latest patents, Lisa has developed innovative glycopyrrolate salts. These salts include solid forms and topical formulations aimed at treating hyperhidrosis. The patents disclose not only the methods of making glycopyrrolate salts but also how these formulations can effectively alleviate the symptoms associated with excessive sweating. This groundbreaking work emphasizes her commitment to improving patient care through innovative pharmaceutical solutions.

Career Highlights

Throughout her career, Lisa has held key positions in notable companies such as Dermira, Inc. and Salix Pharmaceuticals, Inc. Her expertise and dedication have been instrumental in advancing pharmaceutical development, particularly in creating formulations that address unmet medical needs.

Collaborations

In her journey, Lisa has collaborated with skilled professionals in the industry, including Patricia Andres and John Allan Statler. These collaborations have facilitated the exchange of ideas and innovations, further enhancing the effectiveness and reach of her inventions.

Conclusion

With 15 patents to her name, Lisa Lynn McQueen continues to be a pivotal figure in pharmaceutical innovation. Her contributions, particularly in developing glycopyrrolate salts, demonstrate her commitment to advancing medicine and improving patient outcomes. As her career progresses, the impact of her work is expected to resonate in the medical community for years to come.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…